Veeva Systems Inc. (0LO3.L)
USD 213.48
(-1.62%)
USD 213.48
(-1.62%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 525.7 Million USD | 7.79% |
| 2023 | 487.7 Million USD | 14.11% |
| 2022 | 427.39 Million USD | 12.47% |
| 2021 | 379.99 Million USD | 26.2% |
| 2020 | 301.11 Million USD | 31.02% |
| 2019 | 229.83 Million USD | 61.89% |
| 2018 | 141.96 Million USD | 106.33% |
| 2017 | 68.8 Million USD | 26.34% |
| 2016 | 54.46 Million USD | 34.86% |
| 2015 | 40.38 Million USD | 71.01% |
| 2014 | 23.61 Million USD | 25.73% |
| 2013 | 18.78 Million USD | 344.04% |
| 2012 | 4.23 Million USD | 8.21% |
| 2011 | 3.9 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | 147.39 Million USD | 9.06% |
| 2024 Q1 | 131.52 Million USD | -30.24% |
| 2024 Q2 | 111.62 Million USD | -15.13% |
| 2024 FY | 525.7 Million USD | 7.79% |
| 2024 Q3 | 135.15 Million USD | 21.08% |
| 2023 Q3 | 108.45 Million USD | 19.71% |
| 2023 Q1 | 100.11 Million USD | 3.11% |
| 2023 FY | 487.7 Million USD | 14.11% |
| 2023 Q2 | 90.6 Million USD | -9.5% |
| 2023 Q4 | 188.53 Million USD | 73.83% |
| 2022 Q4 | 97.09 Million USD | -8.29% |
| 2022 Q2 | 108.85 Million USD | -5.81% |
| 2022 Q1 | 115.56 Million USD | 12.29% |
| 2022 FY | 427.39 Million USD | 12.47% |
| 2022 Q3 | 105.86 Million USD | -2.75% |
| 2021 Q4 | 102.91 Million USD | 6.15% |
| 2021 FY | 379.99 Million USD | 26.2% |
| 2021 Q1 | 86.57 Million USD | 30.81% |
| 2021 Q3 | 96.95 Million USD | 3.64% |
| 2021 Q2 | 93.55 Million USD | 8.06% |
| 2020 Q1 | 73.44 Million USD | 3.23% |
| 2020 Q3 | 82.24 Million USD | 3.79% |
| 2020 FY | 301.11 Million USD | 31.02% |
| 2020 Q4 | 66.18 Million USD | -19.53% |
| 2020 Q2 | 79.24 Million USD | 7.89% |
| 2019 FY | 229.83 Million USD | 61.89% |
| 2019 Q4 | 71.15 Million USD | 11.03% |
| 2019 Q3 | 64.08 Million USD | 27.44% |
| 2019 Q2 | 50.28 Million USD | 13.49% |
| 2019 Q1 | 44.31 Million USD | 31.46% |
| 2018 FY | 141.96 Million USD | 106.33% |
| 2018 Q3 | 34.39 Million USD | -9.12% |
| 2018 Q4 | 33.7 Million USD | -2.0% |
| 2018 Q1 | 36.02 Million USD | 65.95% |
| 2018 Q2 | 37.84 Million USD | 5.06% |
| 2017 Q1 | 12.5 Million USD | -28.89% |
| 2017 Q4 | 21.7 Million USD | 0.36% |
| 2017 FY | 68.8 Million USD | 26.34% |
| 2017 Q3 | 21.63 Million USD | 66.92% |
| 2017 Q2 | 12.95 Million USD | 3.59% |
| 2016 Q2 | 13.4 Million USD | 3.27% |
| 2016 Q1 | 12.98 Million USD | -2.58% |
| 2016 FY | 54.46 Million USD | 34.86% |
| 2016 Q4 | 17.59 Million USD | 67.81% |
| 2016 Q3 | 10.48 Million USD | -21.81% |
| 2015 FY | 40.38 Million USD | 71.01% |
| 2015 Q4 | 13.32 Million USD | 29.91% |
| 2015 Q3 | 10.25 Million USD | 7.1% |
| 2015 Q2 | 9.57 Million USD | 32.64% |
| 2015 Q1 | 7.22 Million USD | 15.59% |
| 2014 Q2 | 5.99 Million USD | 23.8% |
| 2014 FY | 23.61 Million USD | 25.73% |
| 2014 Q3 | 6.52 Million USD | 8.79% |
| 2014 Q4 | 6.24 Million USD | -4.26% |
| 2014 Q1 | 4.84 Million USD | -14.76% |
| 2013 Q4 | 5.68 Million USD | -1.13% |
| 2013 Q3 | 5.74 Million USD | 0.0% |
| 2013 FY | 18.78 Million USD | 344.04% |
| 2012 FY | 4.23 Million USD | 8.21% |
| 2011 FY | 3.9 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 484.049% |
| Accuray Incorporated | -15.54 Million USD | 3481.827% |
| Align Technology, Inc. | 445.05 Million USD | -18.122% |
| Elevance Health Inc. | 5.98 Billion USD | 91.219% |
| AxoGen, Inc. | -21.71 Million USD | 2520.819% |
| Boston Scientific Corporation | 1.59 Billion USD | 66.999% |
| CVS Health Corporation | 8.34 Billion USD | 93.7% |
| Cardinal Health, Inc. | 852 Million USD | 38.298% |
| Centene Corporation | 2.7 Billion USD | 80.544% |
| DaVita Inc. | 691.53 Million USD | 23.98% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 89.971% |
| Hologic, Inc. | 789.5 Million USD | 33.413% |
| Humana Inc. | 2.48 Billion USD | 78.879% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 37.789% |
| Laboratory Corporation of America Holdings | 418 Million USD | -25.767% |
| Masimo Corporation | 81.5 Million USD | -545.037% |
| McKesson Corporation | 3 Billion USD | 82.488% |
| Patterson Companies, Inc. | 185.93 Million USD | -182.742% |
| Quest Diagnostics Incorporated | 854 Million USD | 38.442% |
| ResMed Inc. | 1.02 Billion USD | 48.508% |
| Henry Schein, Inc. | 416 Million USD | -26.371% |
| Teladoc Health, Inc. | -220.36 Million USD | 338.558% |
| Universal Health Services, Inc. | 717.79 Million USD | 26.761% |
| Baxter International Inc. | 2.65 Billion USD | 80.207% |
| Becton, Dickinson and Company | 1.48 Billion USD | 64.575% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 70.762% |
| Danaher Corporation | 4.2 Billion USD | 87.483% |
| Stryker Corporation | 3.16 Billion USD | 83.39% |
| Medtronic plc | 3.67 Billion USD | 85.699% |